0001862143-21-000001.txt : 20210603 0001862143-21-000001.hdr.sgml : 20210603 20210603124520 ACCESSION NUMBER: 0001862143-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 EFFECTIVENESS DATE: 20210603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Slate Bio, Inc. CENTRAL INDEX KEY: 0001862143 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-401617 FILM NUMBER: 21991894 BUSINESS ADDRESS: STREET 1: 310 2ND STREET SE, SUITE B CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 703-456-8000 MAIL ADDRESS: STREET 1: 310 2ND STREET SE, SUITE B CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 D 1 primary_doc.xml X0708 D LIVE 0001862143 Slate Bio, Inc. 310 2ND STREET SE, SUITE B CHARLOTTESVILLE VA VIRGINIA 22902 703-456-8000 DELAWARE None None Corporation true 2020 Andrew J Krouse c/o Slate Bio, Inc. 310 2nd Street SE, Suite B Charlottesville VA VIRGINIA 22902 Executive Officer Director Kyparissia Sirinakis c/o Slate Bio, Inc. 310 2nd Street SE, Suite B Charlottesville VA VIRGINIA 22902 Director Robert Creeden c/o Slate Bio, Inc. 310 2nd Street SE, Suite B Charlottesville VA VIRGINIA 22902 Director Kurt Woerpel c/o Slate Bio, Inc. 310 2nd Street SE, Suite B Charlottesville VA VIRGINIA 22902 Executive Officer Biotechnology Decline to Disclose 06b false 2020-12-24 false true true Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof. false 0 1999956 1999956 0 false 10 0 0 0 false Slate Bio, Inc. /s/ Andrew J. Krouse Andrew J. Krouse Chief Executive Officer 2021-06-02